A detailed history of Ally Bridge Group (Ny) LLC transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Ally Bridge Group (Ny) LLC holds 270,075 shares of TYRA stock, worth $3.78 Million. This represents 4.51% of its overall portfolio holdings.

Number of Shares
270,075
Previous 264,660 2.05%
Holding current value
$3.78 Million
Previous $4.23 Million 50.06%
% of portfolio
4.51%
Previous 3.97%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$16.7 - $24.36 $90,430 - $131,909
5,415 Added 2.05%
270,075 $6.35 Million
Q2 2024

Aug 14, 2024

BUY
$14.45 - $20.22 $3.82 Million - $5.35 Million
264,660 New
264,660 $4.23 Million

Others Institutions Holding TYRA

About Tyra Biosciences, Inc.


  • Ticker TYRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,973,600
  • Market Cap $588M
  • Description
  • Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...
More about TYRA
Track This Portfolio

Track Ally Bridge Group (Ny) LLC Portfolio

Follow Ally Bridge Group (Ny) LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ally Bridge Group (Ny) LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ally Bridge Group (Ny) LLC with notifications on news.